|
||||||||||||
FDA MedWatch Early Alert
Infusion Pump Software Issue from Baxter This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk issue. The FDA will keep the public informed and update this web page as significant new information becomes available. |
||||||||||||
Affected Product
Spectrum V6 infusion pump startup screen Spectrum V8 infusion pump startup screen The FDA is aware that Baxter has issued a letter to affected customers recommending certain Spectrum Infusion Pumps be removed from where they are used or sold:
What to Do Identify affected Spectrum pumps and remove them from service. Check the software version installed on the pump and contact Baxter to schedule service if required.
Rason for Alert Baxter stated that certain Spectrum infusion pumps may have an incorrect version of software. A software version intended for Spectrum V8 may have been installed on the affected Spectrum V6 pumps, and a software version intended for Spectrum V6 may have been installed on the affected Spectrum V8 pumps. Spectrum software is designed for the pumping mechanism setup specific to each pump platform. The V8 software installed in a Spectrum V6 pump, or vice versa, may cause an inaccurate flow rate of overinfusion or underinfusion, especially over a long run time. Additionally, the V6 and V8 designs include many differences in the clinical workflow and user interface. The appearance of the menus and the requested inputs from the pump are different between the two platforms. If a user who was trained and experienced on a V6 pump was presented with a V6 pump with V8 software, or vice versa, they may experience confusion and delay during use or may accidentally mis-program the infusion. This could result in a delay or interruption of therapy, underinfusion, or overinfusion. The issues described above may lead to serious adverse health consequences such as drug toxicity, overdose, fluid overload, electrolyte imbalances, and delayed or subtherapeutic drug levels causing ineffective treatments. The severity and nature of these outcomes include serious injury and death, and are dependent on the type of medication, fluid, or infusate being delivered and the clinical condition of the patient, with high-risk populations being particularly vulnerable. As of June 12, Baxter has reported no serious injuries or deaths associated with this issue. Device Use Spectrum infusion pumps are intended to provide intravenous infusion of parenteral fluids, blood, and blood products to a patient under the direction or supervision of a physician or other certified health care professional. Contact Information Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact Baxter at corporate_product_complaints_round_lake@baxter.com or 800-843-7867. Unique Device Identifier (UDI) The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.
How do I report a problem? Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. |
||||||||||||
|